Publications
5808 Results
- Journal / Conference
- ISOQOL Meeting (22-25 October 2025 Milwaukee, WI)
- Year
- 2025
- Research Committee(s)
- Palliative Care
- Study Number(s)
- S1316
Patient-reported outcomes (PROs) in the pragmatic comparative effectiveness trial of surgical versus non-surgical management for patients with malignant bowel obstruction (S1316)
- Journal / Conference
- Pharmacogenomics Research Network (PGRN) 2025 Annual Meeting (September 10-12, 2025, Mkssoula, MT)
- Year
- 2025
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
EXTERNAL VALIDATION OF A POLYGENIC RISK SCORE FOR TAXANE-INDUCED PERIPHERAL NEUROPATHY: RESULTS FROM THE SWOG S0221 CLINICAL TRIAL
- Journal / Conference
- ASTRO Annual Meeting (9/27 to 10/1/2025, San Francisco, CA), oral, Abstract #: 258
- Year
- 2025
- Research Committee(s)
- Breast
- Study Number(s)
- S1706
Toxicity in a Randomized Trial Comparing Radiotherapy +/- Olaparib for Inflammatory Breast Cancer
- Journal / Conference
- ASCO GI Cancers Symposium (January 8 - 10, 2026, San Francisco, CA); J Clin Oncol 44, TPS790(2026); DOI: 10.1200/JCO.2026.44.2_suppl.TPS790
- Year
- 2025
- Research Committee(s)
- Palliative Care
- Study Number(s)
- S2408
S2408: A randomized phase III blinded trial of lanreotide for the prevention of postoperative pancreatic fistula
- Journal / Conference
- Journal of Clinical Oncology 2025 Mar 10;43(8):919-928. doi: 10.1200/JCO-24-01507. Epub 2024 Dec 2.
- Year
- 2025
- Research Committee(s)
- Breast
- PMID
- PMID39621968
- PMC
- PMC11885031
- Study Number(s)
- S1007, SWOG-8814
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer
- Journal / Conference
- Clinical Cancer Research Aug 14;31(16):3550-3561
- Year
- 2025
- Research Committee(s)
- Lung
- PMID
- PMID40465842
- Study Number(s)
- LUNGMAP
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non-Small Cell Lung Cancer: A Lung-MAP Study
- Journal / Conference
- Blood Neoplasia Jun 14;2(3):100129
- Year
- 2025
- Research Committee(s)
- Leukemia
- PMID
- PMID40792015
- PMC
- PMC12335950
- Study Number(s)
- S1203
Treatment discontinuation due to toxicity for patients with acute myeloid leukemia receiving intensive induction chemotherapy: Secondary analysis of SWOG S1203
- Journal / Conference
- Oncogene Aug 24. doi: 10.1038/s41388-025-03546-2. Online ahead of print
- Year
- 2025
GABAergic signaling contributes to tumor cell invasion and poor overall survival in colorectal cancer
- Journal / Conference
- European Journal of Cancer Sep 9:227:115694
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID40803104
- Study Number(s)
- CTSU/C80405
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: A combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)
- Journal / Conference
- Blood Cancer Journal May 3;15(1):85
- Year
- 2025
- PMID
- PMID40319052
- PMC
- PMC12049410